citybiz.co

Pillar Biosciences Adds Illumina Executive and ORI Capital Partner to Board

Illumina logoIllumina
Sig1.65Sen+2.25Env0.00Soc0.00Gov+1.70

Pillar Biosciences appointed Illumina executive Todd Christian and ORI Capital partner Yann Echelard to its board after a strategic financing intended to support next-generation sequencing automation and expansion of in vitro diagnostic programs. The financing amount and terms were not disclosed. The directors bring commercialization and diagnostics expertise as Pillar works to broaden adoption of its testing platform.

Coverage (1)

ABOUT

What is Fimmer?

Most feeds treat all company headlines the same. An executive interview, an office closure, stock analysis, and a data breach can sit side by side with no sense of scale. Fimmer ranks coverage by what matters, so important events stand out and signals are prioritised over noise. We cluster related company news and score each story using a range of metrics, so you see the most crucial stories first.

SCORING

What do the scores mean?

Significance (0–10) measures the scale of the real-world impact. Sentiment and ESG (−10 to +10) indicate the tone of the coverage and whether the change relates to environmental, social, or governance factors. Together, these scores help distinguish meaningful developments from routine company news. More information about our scoring methodology can be found on our About page.

DISCOVERY

Explore more on Fimmer

Search more than 10,000 public companies, browse the company index, explore their scores, and read the coverage behind them, with our core features available to everyone for free.

For more advanced features, Pro gives you access to dynamic feeds, custom sorting, and more ways to track the companies that matter to you.

More with Pro